These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 3052875)

  • 1. Enzymatic barriers to peptide and protein absorption.
    Lee VH
    Crit Rev Ther Drug Carrier Syst; 1988; 5(2):69-97. PubMed ID: 3052875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzymatic barriers for GI peptide and protein delivery.
    Woodley JF
    Crit Rev Ther Drug Carrier Syst; 1994; 11(2-3):61-95. PubMed ID: 7600588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent progress in protein and peptide delivery by noninvasive routes.
    Wearley LL
    Crit Rev Ther Drug Carrier Syst; 1991; 8(4):331-94. PubMed ID: 1769066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging strategies for the transdermal delivery of peptide and protein drugs.
    Schuetz YB; Naik A; Guy RH; Kalia YN
    Expert Opin Drug Deliv; 2005 May; 2(3):533-48. PubMed ID: 16296773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absorption of peptides and proteins from the respiratory tract and the potential for development of locally administered vaccine.
    O'Hagan DT; Illum L
    Crit Rev Ther Drug Carrier Syst; 1990; 7(1):35-97. PubMed ID: 2257636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative delivery systems for peptides and proteins as drugs.
    Eppstein DA; Longenecker JP
    Crit Rev Ther Drug Carrier Syst; 1988; 5(2):99-139. PubMed ID: 3052876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral biodrug delivery using cell-penetrating peptide.
    Khafagy el-S; Morishita M
    Adv Drug Deliv Rev; 2012 May; 64(6):531-9. PubMed ID: 22245080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravail: highly effective intranasal delivery of peptide and protein drugs.
    Maggio ET
    Expert Opin Drug Deliv; 2006 Jul; 3(4):529-39. PubMed ID: 16822227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifunctional matrices for oral peptide delivery.
    Bernkop-Schnürch A; Walker G
    Crit Rev Ther Drug Carrier Syst; 2001; 18(5):459-501. PubMed ID: 11763498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microemulsions for improved peptide absorption from the gastrointestinal tract.
    Ritschel WA
    Methods Find Exp Clin Pharmacol; 1991 Apr; 13(3):205-20. PubMed ID: 2051845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Traveling the vitamin B12 pathway: oral delivery of protein and peptide drugs.
    Petrus AK; Fairchild TJ; Doyle RP
    Angew Chem Int Ed Engl; 2009; 48(6):1022-8. PubMed ID: 19072807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonparenteral administration of peptide and protein drugs.
    Siddiqui O; Chien YW
    Crit Rev Ther Drug Carrier Syst; 1987; 3(3):195-208. PubMed ID: 3549006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some approaches to improve bioavailability of peptides and proteins through oral and other mucosal routes.
    Vyas SP; Venugopalan P; Sood A; Mysore N
    Pharmazie; 1997 May; 52(5):339-45. PubMed ID: 9183784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in cell-penetrating, non-peptide molecular carriers.
    Chung SK; Maiti KK; Lee WS
    Int J Pharm; 2008 Apr; 354(1-2):16-22. PubMed ID: 17890027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of advanced oral drug delivery technologies facilitating the protection and absorption of protein and peptide molecules.
    Choonara BF; Choonara YE; Kumar P; Bijukumar D; du Toit LC; Pillay V
    Biotechnol Adv; 2014 Nov; 32(7):1269-1282. PubMed ID: 25099657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Models to predict intestinal absorption of therapeutic peptides and proteins.
    Antunes F; Andrade F; Ferreira D; Nielsen HM; Sarmento B
    Curr Drug Metab; 2013 Jan; 14(1):4-20. PubMed ID: 21933113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies to improve plasma half life time of peptide and protein drugs.
    Werle M; Bernkop-Schnürch A
    Amino Acids; 2006 Jun; 30(4):351-67. PubMed ID: 16622600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential prospects of chitosan derivative trimethyl chitosan chloride (TMC) as a polymeric absorption enhancer: synthesis, characterization and applications.
    Sahni JK; Chopra S; Ahmad FJ; Khar RK
    J Pharm Pharmacol; 2008 Sep; 60(9):1111-9. PubMed ID: 18718113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review: clinical opportunities provided by the nasal administration of peptides.
    Harris AS
    J Drug Target; 1993; 1(2):101-16. PubMed ID: 8069548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The colon as a possible target for orally administered peptide and protein drugs.
    Haupt S; Rubinstein A
    Crit Rev Ther Drug Carrier Syst; 2002; 19(6):499-551. PubMed ID: 12822734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.